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Abstract
Background: Identifying causative biological networks associated with relevant phenotypes is essential in the field of
systems biology. We used ferulic acid (FA) as a model antioxidant to characterize the global expression programs triggered
by this small molecule and decipher the transcriptional network controlling the phenotypic adaptation of the yeast
Saccharomyces cerevisiae.
Methodology/Principal Findings: By employing a strict cut off value during gene expression data analysis, 106 genes were
found to be involved in the cell response to FA, independent of aerobic or anaerobic conditions. Network analysis of the
system guided us to a key target node, the FMP43 protein, that when deleted resulted in marked acceleration of cellular
growth (,15% in both minimal and rich media). To extend our findings to human cells and identify proteins that could
serve as drug targets, we replaced the yeast FMP43 protein with its human ortholog BRP44 in the genetic background of
the yeast strain Dfmp43. The conservation of the two proteins was phenotypically evident, with BRP44 restoring the normal
specific growth rate of the wild type. We also applied homology modeling to predict the 3D structure of the FMP43 and
BRP44 proteins. The binding sites in the homology models of FMP43 and BRP44 were computationally predicted, and
further docking studies were performed using FA as the ligand. The docking studies demonstrated the affinity of FA
towards both FMP43 and BRP44.
Conclusions: This study proposes a hypothesis on the mechanisms yeast employs to respond to antioxidant molecules,
while demonstrating how phenome and metabolome yeast data can serve as biomarkers for nutraceutical discovery and
development. Additionally, we provide evidence for a putative therapeutic target, revealed by replacing the FMP43 protein
with its human ortholog BRP44, a brain protein, and functionally characterizing the relevant mutant strain.
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Introduction
Practically all cellular processes, including every step in the flow
of genetic information from gene expression to protein synthesis
and degradation, can be affected by lifestyle and dietary habits.
Human disorders and nutrient metabolic responses suggest
features whose complexities are defined by interactions among
genes, and between genes and environmental stimuli. These
interactions are often amplified and modulated through regulato-
ry, protein, metabolic and signaling networks. However, our
understanding on the nutrient-related network characteristics and
function is still limited. Exploiting roles of nutritional compounds
for the rational design of strategies to beneficially manipulate cell
functions and/or cell fates is highly restricted by this lack of
information. Network biology provides the opportunity to gain
insight into the structure and function of biological systems, and a
practical scaffold to bridge the gap between reductionistic and
systems biology [1]. More complete knowledge of network
function further enhances our ability to predict quantitative or
qualitative relationships between specific health outcomes and
diverse patterns or levels of nutrient intake in genetically diverse
individuals and populations [2,3].
A fruitful strategy to explore the field of nutritional research is to
use well-established methods applied in medical and pharmaco-
logical research [4]. For example, in analogy to pharmacology,
nutrients can be considered as signaling molecules recognized by
specific cellular sensing mechanisms. However, in nutritional
studies the system response is uniquely confounded by the
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nutrients with diverse chemical structures that have numerous
targets with different affinities and specificities.
A logical approach to successfully overcome the layered
complexity of nutritional research is to dissect, reduce, and classify
the challenges. This approach allows the definition of specific
hypotheses that can be evaluated using an appropriate model
system (Figure 1), and thus obtain clear answers to the research
question being addressed [5,6]. The current enthusiasm for
antioxidants is perhaps of no surprise, as studies suggesting health
benefits from these compounds continue to attract main stream
headlines [7–9]. Yet, even though antioxidants have been studied
for the last 60 years, much about how the human body absorbs
and utilizes such compounds remains unknown. Often, products
boasting health benefits are largely unsubstantiated in their
scientific claims and mechanism of action. Ferulic acid (FA) is
unique among the plant phenolic compounds being a dietary
supplement exhibiting the highest bioavailability among all
flavonoid and monophenolics tested until today. By virtue of its
high scavenging activity against free radicals, its potent membrane
antioxidant properties, and its ability to inhibit enzymes that
catalyze the production of free radicals, FA could as a
nutraceutical play a role in the pre-disease state, either for
improving human health, or for preventing disease.
The importance of FA as a nutraceutical or pharmaceutical
agent against diverse human disorders has been extensively
evaluated. First of all, FA exhibits strong activity against microbes,
including many bacteria and viruses. Secondly, FA and its ester
derivatives decrease the levels of some inflammatory mediators,
such as TNF-a [10]. In addition, FA has been proven beneficial
against cardiovascular diseases, as it decreases the levels of the very
low density (VLDL) and low density (LDL) lipoproteins and
increases the levels of the high-density lipoprotein (HDL)
cholesterol in plasma. Moreover, FA derivatives not only inhibit
collagen-induced platelet aggregation, which is closely associated
with thrombosis, but they are also capable of dissolving thrombi
[11]. Furthermore, FA shows anti-diabetic effects by neutralizing
the free radicals present in the pancreas, and thus helps the beta
Figure 1. Application of bottom-up and top-down systems biology approaches for the development of functional foods that target
specific body functions through either individual ingredients (e.g., resveratrol, ferulic acid, epigallocatechin gallate, EGCG) or
specially designed mixtures (e.g., food ingestion). A discovery process that derives molecular markers for the bioactivity of defined foods
through a human intervention trial, and the use of pathway models (bottom-up) should be followed by an animal model study to verify the markers
in vivo. Similarly, the biomarker signature identification of specific nutrients using nutri-omics technology in yeast (top-down) will eventually be
tested by an intervention study in an animal model. The output of this process, which might well be iterative, is new knowledge obtained for the
biological system, as well as the potential for predictive understanding of that system; in the nutritional arena this would lead to personalized
nutrition.
doi:10.1371/journal.pone.0013606.g001
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insulin levels increase glucose utilization by the extra hepatic
tissues, resulting in lower blood glucose concentration levels [12].
Polyphenols, including FA, reduce proliferative activity and induce
apoptosis in a variety of tumor cells [13]. Finally, a recent study on
rats revealed that orally administrated FA enhances the prolifer-
ation of adult neural stem/progenitor cells in vivo. The same study
suggested a potential anti-depression effect of FA in mice [14].
Conversely, plant phenolic acids are potent inhibitors of
microorganisms and provide a natural protection against patho-
genic infections. Diverse biotechnological or industrial processes
accomplished by S. cerevisiae are affected by such inhibitory
properties. The inhibitory effect of FA and other phenolic
compounds involved in the diverse FA degradation pathways
(e.g. vanillin, coniferyl alcohol, eugenol etc.) on yeast cultures has
recently been confirmed. Specifically, the biomass yield and
growth rate, but not ethanol yield, are highly affected by the
presence of FA and its related compounds [15]. Interestingly, S.
cerevisiae has been shown to convert FA into vinyl guaiacol (4-
hydroxy-3-methoxy styrene) in 96% yield and diFA (4-hydroxy-3-
methoxy phenylpropionic acid) in 54% yield under an atmosphere
of argon [16].
A new biomarker concept to predict human health effects of
nutrients and develop nutraceuticals based on systems and
network biology is presented here. We characterize the pathway
responses of S. cerevisiae upon defined perturbations: controlled
environmental stimuli using an antioxidant model compound,
deletion of a gene –whose protein product constitutes a significant
node of the network architecture– and insertion of its human
ortholog, and we assess their interaction by integrating such
information into graphical network models, which elucidate
predictive hypotheses to explain emergent behaviors.
Materials and Methods
Strains and media
The haploid, prototrophic S. cerevisiae strain CEN.PK 113-5D
(MATa SUC2 MAL2-8
c ura3-52) was used in all cultivations.
Cultures were maintained by plating in YPD medium and such
stocks were used to inoculate the pre-cultures. Pre-cultures were
prepared in shake flasks using defined mineral medium [17],
supplemented with vitamins, adjusted to pH 6.0 and containing
2% (w/v) glucose. For anaerobic cultivations, the medium was
supplemented with Tween 80 and ergosterol. When needed, FA
was added with sterile filtration in a final concentration of 0.8 g/L.
Construction of the yeast strain
CEN.PK 113-5D/Dfmp43. The strain CEN.PK 113-5D with
the single FMP43 deletion was created using a two-step gene
deletion strategy [18]. The upstream and downstream regions of
FMP43 were amplified using the genomic DNA of strain CEN.PK
113-5D as a template. Kluyveromyces lactis URA3 was amplified as
two overlapping fragments2referred to as upstream and
downstream2 using two primer pairs and the plasmid pWJ1042
as a template. The amplified upstream fragment of FMP43 was
fused to the upstream fragment of URA3, and the FMP43
downstream fragment was fused to the URA3 downstream
fragment. These two fusion fragments were used as
transformation material for the strain CEN.PK 113-5D. A total
of 10 Ura
+ transformants 2grown on synthetic complete (SC)
Ura
2 medium2 were streak-purified and re-streaked on SC plates
containing 5-fluoroorotic acid (5-FOA, Zymo Research) to
selectively loop out the K. lactis gene. The 5-FOA-resistant
colonies were picked out and checked for loss of URA3 by
replica plating on SC-Ura
2 plates. The deletion of FMP43 was
confirmed by PCR (see Table S8).
Construction of the yeast strain
CEN.PK 113-5D/Dfmp43/pRS426-BRP44. The synthetic,
codon-optimized BRP44 expressed on pUC19 was purchased from
Codon Devices, Inc. Restriction endonucleases, enzyme buffers
(NEB) and bovine serum albumin (BSA) were purchased from
New England Biolabs, Inc. The frame for cloning of the BRP44
fragment, i.e pRS426, was a vector kindly provided by Dr S.
Wattanachaisaereekul. The extraction of the pRS426 or pRS426-
BRP44 DNA from E. coli DH5a cells was achieved using the
GenElute Plasmid Miniprep Kit from Sigma-Aldrich, Co. For the
purification steps, the QIAEX II Gel Extraction Kit from Qiagen
was used.
Liquid cultures of E. coli DH5a cells used during cloning were
prepared in 5 mL lysogeny broth (LB) in sterile 15 mL tubes and
left to shake at 150 rpm overnight at 37uC. The medium
contained 10 g tryptone, 5 g yeast extract, and 10 g NaCl pr.
liter, taken to pH equal to 7.0 with NaOH prior to autoclavation.
The ligation product was transformed into strain CEN.PK 113-
5D/Dfmp43 to over-express BRP44, and the Ura
+ phenotype was
selected on SC-Ura
2 plates.
Batch and chemostat cultivation conditions
To determine the physiological characteristics of the different
yeast strains in the presence and absence of FA, the S. cerevisiae
control and recombinant strains were grown in batch cultivations
in well-controlled 2 L bioreactors with a working volume of 1.5 L.
The chemostat cultivations (at 0.1 h
21dilution rate) were per-
formed in the same advanced bioreactors with 1 L working
volume. The bioreactors were provided with the defined mineral
medium described above, containing glucose (2% w/v) as the
limited nutrient. The bioreactors were equipped with two disc-
turbine impellers rotating at 600 rpm. The pH was kept constant
at 5.0 by addition of 2 M KOH or HCl, and the temperature was
maintained at 30uC. Air or nitrogen was used for sparging the
bioreactor at a constant flow rate of 1.0 vvm (volume of gas per
volume of liquid per minute).
Analysis of substrates and products
Cell dry weight was determined using nitrocellulose filters (pore
size 0.45 mm, Gelman Sciences). Fermentation samples were
immediately filtered and stored at 220uC until analysis. The
concentrations of glucose, ethanol, glycerol, acetate, succinate,
pyruvate and FA were determined by HPLC as previously
described [19,20]. Yields and production/consumption rates were
calculated in C-moles.
Sampling, extraction, determination and analysis of
intracellular and extracellular intermediary metabolites
For the analysis of intracellular and extracellular metabolites,
triplicate biological samples were collected and immediately
quenched in cold 72% v/v methanol (240uC) as previously
described [21]. The lyophilized samples were derivatized using
methyl chloroformate, and amino and non-amino organic acids
were analyzed by GC-MS [22]. GC-MS analysis was performed
with a Hewlett-Packard system HP 6890 gas chromatograph
coupled to a HP 5973 quadrupole mass selective detector (EI)
operated at 70eV. The profile of identified intracellular and
extracellular amino and non-amino organic acids was expressed in
peak areas normalized by the mass of biomass.
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Biomass samples were collected rapidly to limit any potential
changes to the transcriptional profiles of the strains. Forty mL of
culture broth was sampled directly from the bioreactor into a
50 mL centrifuge tube containing crushed ice. After vigorous
stirring, the sample froze instantly. The cells were pelleted
(5000 rpm at 0uC for 4 min), and RNA was extracted using the
hot-phenol method [23]. RNA quality was checked using the
Agilent 2100 Bioanalyzer. Fifteen mg of fragmented biotin-labeled
cRNA was prepared from 5 mg of total RNA and hybridized to the
YEAST 2.0 Affymetrix GeneChip according to the Affymetrix
GeneChip expression analysis technical manual [24].
Analysis of transcriptome data
The differential gene transcription caused by the presence of FA
under aerobic and anaerobic chemostat cultivations (D=0.1 h
21)
was examined. The scanned probe array images (.DAT files) were
converted into CEL files using the default values of the GeneChip
operating software (version 1.4) from Affymetrix. The probe-level
data in CEL files were subsequently processed using the statistical
open source language R (version 2.5) [25]. Data pre-processing
was carried out using the robust multichip average (RMA) method
[26], which is available in the affy package [27]. This package
implements RMA by correcting the perfect match (PM) probes,
performing quantile normalization [28] and calculating the
expression measure by using median polish.
The effects of FA were examined by 262 ANOVA statistical
analysis of different subgroups (sg); sg1:(+)O2(6FA) vs.
sg2:(2)O2(6)FA vs. sg3:(6)O2(-FA) vs. sg4:(6)O2(+FA), to identify
significantly differentially expressed genes being FA-responsive,
independent of oxygen supply. Statistical analysis to determine
genes subject to differential transcription regulation was performed
using the limma package [29]. Moderated t-tests were used for the
comparison of FA effect on yeast cells. For all comparisons, we
used empirical Bayesian statistics to moderate standard errors
within each gene and the Benjamini-Hochberg’s method to adjust
p-values for multiple testing [30]. To determine statistically
significant gene expression changes, the logarithmic fold change
was higher than 1 and the highest cut off value for the calculated
adjusted p-values was set at 0.001.
Bioinformatic tools and software
Cytoscape (version 2.5.2) [31] was used for the PPI network
analysis, where several plug-ins were applied to the resulted sub-
networks: Molecular COmplex DEtection (MCODE, version 1.3),
Biological Networks Gene Ontology (BiNGO, version 2.0),
jActiveModules (version 2.23), and cell region-based rendering
and layout (Cerebral, version 1.2). The MCODE algorithm was
applied by using the following parameters: for network scoring, a
degree cutoff of 2 was chosen, while loops were not included. For
cluster finding, the node score cut off was 0.2, haircuts (but not
fluffs) were considered, k-core was equal to 2, and the maximum
depth from seed was set to 100. During BiNGO application for the
study of biological process (BP) enrichment in the data, the
hypergeometric statistical test was chosen, while for multiple
testing correction the Benjamini-Hochberg false discovery rate
(FDR) method with a significance threshold of 0.05 was applied.
To derive the corresponding functional enrichment, each protein
complex or selected network region was tested versus the whole
available set of genome annotation. The GENECODIS tool [32]
was also used for the gene ontology analysis of the ACTMOD
network, and specifically for the cellular component (CC)
enrichment analysis of the latter. During GENECODIS applica-
tion, the hypergeometric statistical test without p-value correction
was chosen to retrieve CC term enrichments at the lowest level.
During the study of reporter features resulting from the
transcriptional profiles of the yeast strains Dfmp43 and WT, the
REPORTER FEATURE software (version 5.0) was used [33].
Also, diverse databases were explored throughout the present work
(data downloaded in September 2009): eukarYOtic ortholoGY
(YOGY, www.sanger.ac.uk/PostGenomics/S_pombe/YOGY),
Saccharomyces Genome Database (SGD, www.yeastgenome.org),
YEASTRACT (www.yeastract.com), PubMed (www.ncbi.nlm.nih.
gov), BLAST (www.ncbi.nlm.nih.gov/blast/Blast.cgi), and Uni-
Prot (www.uniprot.org). Predictions for the FMP43 protein were
performed using multiple servers available at the Center for
Biological Sequence analysis (CBS, Kgs. Lyngby, Denmark):
ProtFun (version 2.2), TMHMM (version 2.0), NetNES (version
1.1), SignalP (version 3.0), TargetP (version 1.1), NetPhosYeast
(version 1.0), NetAcet (version 1.0) and YinOYang (version 1.2).
Homology modeling and structure validation: Sequences of PDB
structures showing similarity with the BRP44 and FMP43 amino
acid sequences were retrieved from the RCSB Protein Data Bank
using different cut offs for E-values. Secondary structure analysis of
the BRP44, FMP43 and template sequences was accomplished
using the SOPMA secondary structure prediction method.
Homology modeling of both BRP44 and FMP43 proteins was
performed using the Swiss-PdbViewer. The ProSA-web protein
structure analysis tool was used to validate the overall quality of
structural models obtained from homology modeling. The
compatibility of atomic model (3D) with its own amino acid
sequence was analyzed using the Verify3D structure evaluation
server. The stereo-chemical quality of each protein structure was
checked using the Procheck program. We used the Protein
Structure Validation software suite to determine statistical
parameters of structure quality factors.
Prediction of protein-ligand binding sites
Protein-ligand binding sites in BRP44, FMP43, FAEA (Asper-
gillus niger) and FAE domain of xyn10B (Clostridium thermocellum)
were predicted using the Q-SiteFinder tool. Q-SiteFinder works by
binding hydrophobic (CH3) probes to the protein, and then
finding clusters of probes with the most favorable binding energy.
These clusters are ranked according to the sum of total binding
energies, indicating the likelihood of each cluster to be a binding
site.
Molecular Docking
Chemical Entities of Biological Interest (ChEBI), a freely
available dictionary of molecular entities, was used to retrieve
FA in the Mol format. Protein-ligand docking studies using
Lamarckian genetic algorithm scoring functions to find the low-
energy binding mode were employed in the ArgusLab software.
Results
Phenotypic biomarkers in S. cerevisiae cultivations reveal
the presence of an antioxidant molecule
The S. cerevisiae CEN.PK 113-5D (CON) was grown at aerobic
and anaerobic conditions in well- controlled bioreactors in the
presence and absence of FA using defined medium with glucose as
the sole carbon source. CON was capable of growing aerobically
and anaerobically in the presence of FA at a specific growth rate
(mmax) of 0.23 h
21and 0.15 h
21, respectively. This result shows the
paramount effects of FA 2when added in deleterious concentra-
tions2 on the physiology of yeast cells and in particular on growth,
Nutraceuticals & Yeast
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oxygen supply, respectively) compared with the cultivations
without FA (Table 1).
Underaerobicconditions,thepresenceof FAreduced markedlythe
glucose consumption rate, rs, as well as the biomass production rate,
rx. However the most devastating effect of FA was on the ability of the
cells to respire. In the presence of FA, the determined maximum
specific consumption rate of oxygen was 2.1 mmol/g-DW/h, which
corresponds to a 4-fold decrease when compared with the condition
where no FA was supplemented (Table 1). The yield and productivity
of acetate and ethanol, which constitute two common metabolites in
yeast metabolism 2both originating from pyruvate with different
redox cofactors involved in their pathways2 were also affected by the
addition of FA. In both aerobic and anaerobic cultivations, acetate
level was increased by FA supplementation, while the opposite trend
was observed for ethanol. Furthermore, at aerobic conditions and in
the presence of FA, yeast showed lower respiratory capacity resulting
in inability to consume ethanol after glucose depletion (data not
shown). In addition, under anaerobic cultivations and in the presence
of FA, the carbon evolution rate (CER) was represented by one wide
peak (data not shown), reaching the maximum value when the glucose
concentration in the medium was 8–9 g/L. This indicates that the
impact of FA on yeast is extended to mechanisms other than simply
respiratory metabolism.
Reflection of the antioxidant activity of FA on the
metabolome of the yeast cell
To further evaluate the effect of FA glucose-limited chemostat
experiments were performed at a dilution rate of D=0.1 h
21
under both aerobic and anaerobic conditions and in the
presence and absence of FA. This experimental set-up facilitates
the direct measurement of the impact of FA on the endo-
metabolome of the yeast S. cerevisiae avoiding growth-rate
associated trends. All carbon-containing substrates can be
oxidized to CO2, and relative to this end product of biochemical
reactions, the substrates and the carbon-containing metabolic
products are in the reduced state. The degree of reduction
(DOR) is a systematic way of defining the redox level of different
chemical compounds. A higher value of the DOR indicates a less
oxidized compound.
To evaluate the applicability of the S. cerevisiae platform for
antioxidant discovery, the oxidative state of the 45 measured
amino and non-amino organic acids was calculated using the
DOR of each metabolite (Table S1). The value for the metabolite
with the highest DOR was arbitrarily assigned to 1, and all the
other metabolites were accordingly linearly scaled. The ratio of the
concentration of each intracellular metabolite in the presence
versus absence of FA was plotted against the DOR of the
metabolite. By comparing the level of the intracellular metabolites
under aerobic conditions, with and without FA, we observed that
the presence of FA increased the concentration of metabolites with
DOR higher than the average value (0.77) and decreased the
concentration of metabolites with DOR values lower than the
average, supporting the compound’s antioxidant potential. The
exact same trend was observed for the metabolites that had higher
concentrations under anaerobic conditions and when FA was
present. However, the metabolites being at higher levels during
anaerobic and without FA cultivations were more scattered
Table 1. Physiological characterization of S. cerevisiae (CON), with and without perturbation by an antioxidant compound (FA),
under aerobic and anaerobic conditions.
Aerobic Cultivation Conditions Anaerobic Cultivation Conditions
(-)FA (+)FA (-)FA (+)FA
mmax, h21 0.34 0.23 0.29 0.16
Specific Production/Consumption Rates C-mmol/g-DCW/h
C-mmol/g-
DCW/h
Glucose 100.21 80.29 93.11 66.42
Biomass 10.69 6.85 12.48 5.61
Ethanol 44.28 34.27 41.03 25.95
Acetate 0.17 0.23 0.36 0.41
Glycerol 5.53 4.81 10.46 7.71
Pyruvate 0.37 0.16 0.33 0.13
CO2 11.57 7.21 11.06 4.97
O2 8.04 2.09 nd nd
Yields
C-mol/C-mol
glucose
C-mol/C-mol
glucose
Biomass 0.107 0.085 0.134 0.084
Ethanol 0.442 0.427 0.441 0.391
Acetate 0.002 0.003 0.004 0.006
Glycerol 0.055 0.061 0.112 0.116
Pyruvate 0.004 0.002 0.004 0.002
CO
2 0.115 0.091 0.119 0.075
O2 0.08 0.026 Nd Nd
All values were calculated in batch culture (biological triplicates) during exponential growth phase on glucose, and identified by the linear relationship between the
natural logarithm of biomass and the culture time.
doi:10.1371/journal.pone.0013606.t001
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related to the oxidative status of the cell.
Uncovering the complexity of the yeast network
response evoked by an antioxidant
By employing a strict cut off value (padjusted,0.001), 106 genes
were found to be involved in the cell response triggered by FA,
independent of aerobic or anaerobic conditions (Table S2). The
list was further reduced for subsequent analysis by removing genes
that appear not to have a human ortholog 2with the aim to
propose conserved mechanisms used from yeast to humans. The
remaining 73 genes were submitted to the SGD and STRING
databases (Table S3) to retrieve high quality protein-protein
interactions (PPIs). However, data could be obtained for only 64 of
the 73 genes. The files were imported into the Cytoscape software
and the resulted FA-specific network, consisting of 3,251 nodes
and 12,462 edges, is displayed in Figure 2A.
To find densely connected regions in the molecular interaction
network, MCODE, a density-based local search algorithm, was
applied. The predicted protein complexes contained several
known molecular complexes, but the majority of genes that were
both functionally connected and present in the original gene list
(64 genes) corresponded mainly to procedures, like translation,
regulation of progression through the cell cycle, transcription,
aerobic respiration and protein phosphorylation (Table S4).
To identify causative networks associated with the observed
phenotypic response to the FA-stimulus, we integrated the PPI
data with the expression data. Due to the fact that topologically
interesting nodes tend to represent key regulatory elements of
signaling cascades, while differentially expressed genes are likely to
be found among target genes whose expression is regulated by
these cascades, a combined analysis could provide new insights in
the molecular mechanisms underlying the antioxidant activity of
small molecules. We identified 3 highly active sub-networks (Z-
scores ranging from 6.6 to 7.2, with scores higher than 3
Figure 2. Understanding the dynamic programs that a yeast cell utilizes in response to the external stimulus of an antioxidant
compound. (A) The primary FA-specific protein-protein interaction (PPI) network (3,251 nodes, 12,462 edges) constructed by the list of the 64 genes
that significantly responded to the FA environmental perturbation, independently of the aeration level, (B) High-scoring active modules identified in
the primary FA-specific PPI network. Bold font indicates genes that belong to the list of the 64 genes, (C) The ACTMOD network, consisting of 167
nodes and 1,651 edges, using the ‘‘organic layout’’ in Cytoscape, (D) Sub-cellular localization of the 167 nodes of the ACTMOD network,
(E) Functional enrichment (biological process, BP) of the ACTMOD network. For some nodes no functional annotation could be retrieved. During
visualization feature assignment, color and shape codes have been defined as follows. Shape code: OCTAGON was used to indicate genes with
significant differential expression in the (+)FA(+)O2 vs. (+)FA(2)O2 t-test, TRIANGLE for genes with significant differential expression in the (+)FA(2)O2
vs. (2)FA(2)O2 t-test, ROUND RECTANGULAR for genes with significant differential expression in the ANOVA statistic, and PARALLELOGRAM for
genes with significant differential expression in the (+)FA(+)O2 vs. (2)FA(+)O2 and (+)FA(2)O2 vs. (2)FA(2)O2 t-tests. Color code: GREEN indicates
down-regulation, while RED indicates up-regulation.
doi:10.1371/journal.pone.0013606.g002
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the next analysis step, the two network concepts introduced by
MCODE and jActiveModules algorithms were linked together by
merging the corresponding algorithmic outputs in Cytoscape. The
resulting network (174 nodes and 1,687 edges) consisted of four
sub-networks: one large (149 nodes and 1,580 edges) and 3 smaller
(12 nodes and 58 edges; 9 nodes and 33 edges; 4 nodes and 14
edges) sub-networks.
We further investigated the potential connectivity among these
sub-networks. To do so, we extracted from the primary FA-specific
network the first neighborhood of nodes, which appeared as
significantly differentially expressed in the original gene list (64
genes), and then we imported the corresponding small networks in
Cytoscape and checked their connectivity to the larger network.
This procedure was followed separately for each sub-network. In
this manner, we observed that the larger sub-network was
interconnected to only one of the remaining three sub-networks,
while the resulting network was named ACTMOD network (167
nodes and 1,651 edges) and is shown in Figure 2C.
Subsequently, the ACTMOD network was studied for node
sub-cellular localization. As indicated in Figure 2D, nodes were
localized in almost every cellular compartment, however, most of
the nodes belonged to the yeast mitochondrion, where the
majority of reactive oxygen species (ROS) species is generated.
To understand the functional connectivity of the ACTMOD
network, we determined the GO terms being significantly over-
represented. The results were in agreement with those observed
when the MCODE algorithm was applied to the primary FA-
specific network, showing high confidence enrichment for
translation (p=5.51610
219), protein amino acid phosphorylation
(p=1.22610
212), aerobic respiration (p=3.11610
203), transcrip-
tion (p=1.48610
202), amino acid metabolism (p=1.61610
202)
and regulation of progression through the cell cycle
(p=4.80610
202) (Figure 2E). It should be noted that functional
annotation has not been assigned to all 167 nodes of the
ACTMOD network, with the highly connected nodes of the
FMP43-associated protein complex representing the majority of
such nodes (Table S5).
Transcriptional regulation leads to a novel gene-target of
antioxidant components
To be clinically relevant, results as those obtained above need to
be translated and reduced to the level of a testable hypothesis
about individual genes and proteins within the condition of
interest. By integrating information from network connectivity and
gene expression data, a list of 13 genes 2present in the MCODE
clusters, active modules and the ANOVA list of significant genes2
was obtained (Figure 3A). We examined the transcriptional
regulation of these set of genes, and as shown in Figure 3B, a
very tight regulatory network controls the expression of all 13
genes with more than 20 transcription factors (TFs) being
involved. A literature survey on these TFs revealed that a fraction
of them has a crucial role in different stress responses in yeast
(Msn4, Yap1, Xbr1, Msn2, and Gat4). A second set of
transcriptional regulators is involved in the cell cycle progression
(Rme1, Ume6, Sok2, Mcm1 and Yhp1), while the function of one
TF (Adr1) is connected with the activation of genes involved in
ethanol consumption, a phenotypic deficiency observed during our
batch cultivations.
A third group of TFs was one of the main coordinators of the
fine-tuning of the yeast response to FA (Figure 3C). Rpn4 encodes
a transcription activator that induces the proteasome genes, and
recent studies have led to a model in which the proteasome
homeostasis is regulated by a negative feedback circuit, a
mechanism that exists also in higher eukaryotes, including humans
[34,35]. In one of these studies, it was demonstrated that down-
regulation of the proteasome genes, regulated by Rpn4, was able
to reduce the active proteasome levels, a finding with potential
clinical relevance in cancer cells [36]. Aft1 is another TF that
controls the activation of 40% of the up-regulated genes in
response to neurotoxicants [37]. Recent studies have elucidated
the mechanisms of neural damage associated with these com-
Figure 3. Integrating information from network connectivity and gene expression data. (A) The Table contains 13 genes that were
present in our initial FA-specific gene list (ANOVA), and simultaneously in the significant MCODE clusters and the identified high-scoring active
modules. (B) The transcriptional regulatory network (24 TFs) controlling the expression of the 13 genes. (C) A sub-network with the 7 TFs that
regulate the expression of FMP43 protein. Grey font: Transcription factors, White font: Genes regulated by these TFs.
doi:10.1371/journal.pone.0013606.g003
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symptoms [38]. Prd1p and Pdr3p together confer resistance to
several drugs through transcriptional activation of ABC transport-
er genes and members of the major facilitator super- family of drug
efflux pumps, resulting in the expulsion of various structurally
unrelated molecules. Pdr1p directly binds to xenobiotics to
activate genes, and interacts physically and functionally with the
Gal11p/MED15 subunit of the Mediator [39]. The Mediator co-
activator interacts with RNA polymerase II [40], which is in
agreement with our observation that transcription (mediated
mainly by RNApolII) is one of the most significant biological
processes the ACTMOD network is significantly enriched for
(Figure 2E).
The Yap family belongs to the bZIP super-family of TFs and the
majority of its members are conserved from yeast to human. One of
the family members, Yap8 (Arr1), appears in Figure 3C and shows
accelerated evolution to the average of the genome [41], which is
consistent with the hypothesisthatYap8 isunder positive selection to
fulfill a wider genetic program required to deal with new
environmental stimuli. Reb1 protein is an essential, auto-regulated
DNA-binding protein that binds to many sites in the S. cerevisiae
genome. Van Slyke et al. [42] showed that Reb1p is likely to play an
important role in the complex regulation of CLB2 product 2a
protein with a central distinct role among the cyclins2 which will in
turn influence the timing or progression of the cell cycle, or the
budding process. Consequently, identification of other proteins that
affectthispromoter andtheir interactions willallow ustounderstand
not only the regulatory circuitry of CLB2, but also the mechanisms
by which cell cycle is regulated. Sko1 is also a basic leucine zipper
(bZIP) TF of the ATF/CREB family. In a recent breakthrough on
our understanding on cell cycle control, Niu et al [43] observed that
over-expression of the TF Sko1 arrest cells at G1 phase by activating
the pheromone response pathway, supporting the notion that many
genes may gain function upon over-expression [43].
Surprisingly, the 7 highly interconnected TFs described above,
regulate the expression of a gene with unknown function, FMP43
(Figure 3A and C), whose expression level was very high under all
conditions tested in this study and significantly differentially
expressed by FA addition. The identification of FMP43 as one of
the primary contributors of the environmental and internal sensing
mechanisms to achieve network dynamics attracted our attention.
Subsequently, we further explored how the phenotypic biomarkers
and the network robustness are affected by redundancy and
degeneracy of this protein and its human ortholog.
Functional screening and post-translation predictions
highlight the essential role of the FMP43 protein
Interestingly, the FMP43 protein belongs to a complex of 16
proteins (Figure 2E) with 10 of them being putative proteins with
unknown function (Table S6). In addition, BRP44, a human brain
protein, is the ortholog of FMP43 protein. We further investigated
the role of FMP43 using a variety of bioinformatics prediction
servers. The ProtFun2.2 server identified FMP43 as a structural
protein 2supporting our hypothesis for its putative role in the
regulation of essential cellular responses to internal or external
signaling2 involved in the energy metabolism. FMP43 does not
contain any transmembrane segments, it is a non-secretory
protein, and despite its small size, it has 5 phosphorylation sites
(Table S7). In the significantly differentially expressed genes of the
ANOVA list, there were only 2 protein kinases, the Gut1 2a
glycerol kinase2 and the Sip2 kinases. Sip2 is one of the three b-
subunits of the Snf1 complex and its loss (sip2D) results in
accelerated aging phenotype [44]. If the Sip2 kinase is involved in
the phosphorylation of FMP43, it is possible that the unique
(among the Snf1 b-subunits) effect of Sip2 on aging could be
reproduced through alterations in the expression level of FMP43.
We summarized the significant effects that the FMP43 deletion
had on yeast physiology in Table 2. The maximum specific growth
rate was 0.34 h
21(corresponding to doubling time of ,122 min)
for the reference strain (CON) and 0.39 h
21 (corresponding to
doubling time of ,106 min) for the strain Dfmp43 (FMP), which
corresponds to an approximately 15% growth rate increase.
Similarly, a 13% increase in the specific growth rate caused by the
deletion of FMP43 was also observed when the medium was
supplemented with FA. Specifically, the CON strain had
maximum specific growth rate of 0.23 h
21 (corresponding to
doubling time of ,180 min), and the FMP strain had maximum
specific growth rate of 0.26 h
21 (corresponding to doubling time
of ,160 min). This presumably indicates that the effect of FA on
the FMP43 protein is exhibited as the result of a direct interaction
rather than through a signaling cascade. Additionally, we found
that the biomass yield of the FMP strain was increased by 72%
compared with the biomass yield of the CON strain, which
demonstrates that FMP43 deletion triggered changes in the central
carbon metabolism in favor of biomass production. This result
correlated well with the observed increase in both the CO2 and O2
yields for the FMP strain (Table 2). However, when FA was added
in the medium, the yields of the different metabolic products on
glucose were not significantly altered (Table 2), possibly because
the toxic effect of the high FA concentration (Table 1) partially
counter-affected the phenotype of the FMP43 mutant.
In actively dividing cells, cell size reflects the balance between
growth and division. Environmental or genetic perturbations, such
as addition of a compound in the culture medium or gene
deletions, could shift the balance in favor of growth. Such shift
could be either due to higher growth rate of the cells or a delay in
division, and it inevitably results in increase of the cell size [45,46].
These principles apply to the present study, where a gene deletion
resulted in higher growth rate (with or without FA in the culture
medium), and thus higher cell size and biomass yield for the
constructed mutant compared with the wild type. This interpre-
tation also implies that cell cycle progression could be affected. A
recent study showed that the ability of yeast cells to grow changes
during the cell cycle. Specifically, during the normal cell cycle,
Table 2. Specific growth rates and production/consumption
yields (C-mole/C-mole glucose) in the presence and absence
of ferulic acid (FA) of the S. cerevisiae control strain (CON), the
S. cerevisiae FMP43 deletion mutant (FMP) and the S.
cerevisiae mutant with FMP43 protein being replaced by the
human BRP44 orthologue (HUM).
Strains (2)F A mmax (h
21)biomass O2 CO2 Ethanol
CON 0,34 0,107 0,081 0,115 0,442
FMP 0,39 0,184 0,093 0,142 0,454
HUM 0,34 0,144 0,077 0,108 0,437
(+)F A
CON 0,23 0,085 0,026 0,09 0,427
FMP 0,26 0,084 0,029 0,09 0,409
HUM 0,26 0,153 0,042 0,13 0,374
All values were calculated in batch culture (biological triplicates) during
exponential growth phase on glucose, and identified by the linear relationship
between the natural logarithm of biomass and the culture time.
doi:10.1371/journal.pone.0013606.t002
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boundary, while the ability of cells to grow is higher in anaphase-
and G1-arrested cells than in any other cell cycle stage [47]. If cell
cycle progression in the FMP mutant is indeed altered, then we
hypothesize that FMP43 protein is related to and somehow affects
key regulatory mechanisms governing the cell cycle, as for instance
the G1/S-phase control point. Additional experiments, to detect
any cell cycle dissimilarity of the FMP strain compared to the
CON strain, are needed. Flow cytometry experiments 2using the
propidium iodide to stain nuclear DNA or a more sensitive DNA
stain2 would be suitable to this direction.
The genome-wide transcription response of the CON and FMP
strains, when both were grown in triplicates, resulted in 985 genes
with differential expression (padjusted,0.01). According to the GO
term finder of the SGD database, the products of differentially
expressed genes in the FMP relative to the CON strain showed
functional enrichment for metabolic process (p=2.45610
205) and
cellular component organization (p=9.68610
205). For the same
gene list, GENECODIS tool has reported co-occurrence annota-
tion enrichment for cellular respiration (BP) and mitochondrial
ribosomes (CC) (p=8.70610
206).
The transcriptional changes were superimposed on the
metabolic network to identify metabolic units that changed in
response to the FMP43 deletion. By using an algorithm that
detects metabolic modules based on biologically significant
changes in gene expression [33], the ‘reporter metabolites’, i.e.
the metabolites around which significant coordinated gene
expression occurs, were identified. The top reporter metabolites
are presented in Table 3.
We evaluated the significance of these metabolites as putative
biomarkers in human clinical studies by retrieving relevant
information from the Human Metabolome Database (HMDB).
HMDB (www.hmdb.ca) is a database containing detailed data on
small molecule metabolites found in the human body. It was very
interesting that abnormal concentration of 4 of the 13 top reporter
metabolites in Table 3 have been associated with prostate cancer.
By surveying the HMDB for metabolites that are associated with
the human prostate cancer, 360 hits were found (data downloaded
in August 2010). As the performed search returned hits for both
key words used (‘prostate’ and ‘cancer’), we then filtered the list
retrieved. During the filtering procedure, only hits that showed
well-proven association to prostate cancer were kept. These are
metabolites for which abnormal quantitative data under disease
state exist. Hits that referred to either key words only, or positive
hits restricted to specific groups of men (e.g. men exposed to N-N-
dimethylformamide), or hits commonly used for prostate cancer
treatment and prevention purposes, were eliminated.
The filtering procedure indicated 44 metabolites, whose
abnormal concentration level is closely linked to the prostate
cancer development and progression. On the next step, we
investigated the overlap between this metabolite list and the whole
set of metabolites reported in the REPORTER FEATURE
software. The overlap group consisted of 9 metabolites. The
significance of our finding, that 4 out of the top 13 identified
reporter metabolites are associated with prostate cancer, was
evaluated by implementing a hypergeometric distribution test,
where the calculated p-value (1.33610
204) confirmed the statistical
significance of our finding.
The human brain protein BRP44 restores the wild type
phenotype of S. cerevisiae
To investigate the functionality of the human ortholog of the
FMP43 protein in S. cerevisiae, we inserted the human gene in the
genetic background of the yeast strain Dfmp43 (HUM). Surpris-
ingly, the replacement of the FMP43 by the BRP44 protein
reinstated the specific growth rate at the same value as the yeast
control strain (CON) (Table 2). In addition to the specific growth
rate, the expression of the BRP44 protein restored the majority of
metabolite yields on glucose (O2,C O 2 and ethanol) with the
exception of biomass yield, which was significantly higher for the
HUM strain compared with the yield of the CON strain (Table 2).
However, when FA was added in the medium the growth
characteristics of the HUM strain were different from those of the
CON strain (Table 2), supporting our previous hypothesis on
direct interaction between this small molecule and the target
protein, in this case the BRP44 protein (or, as previously
suggested, the FMP43 protein).
We verified this hypothesis by performing protein-ligand
binding site predictions and molecular docking studies for the
BRP44 protein and FA. Firstly, we performed homology modeling
and structure validation of the BRP44 protein. A total of 62 PDB
templates with different E-value cut offs for amino acid sequence
similarity with BRP44 were obtained from PDB advanced search
interface. These templates were shortlisted based on resolution,
sequence similarity and secondary structure similarity (SOPMA),
covering the maximum range of the BRP44 sequence. A total of
three templates were shortlisted and their secondary structure
alignments are shown in Table S9.
Three homology model structures for BRP44 were built using
three different combinations of templates. The ProSA-derived Z-
scores for BRP44 Model 1, BRP44 Model 2, and BRP44 Model 3
were 21.91, 21.91 and 20.24, respectively. Even though the Z-
scores of BRP44 Model 1 and BRP44 Model 2 are similar, some
distortions were observed in BRP44 Model 2 (not shown here).
Ramachandran plot summaries of BRP44 Model 1 and its
respective templates (obtained from Procheck program) are shown
in Table S9. Based on the analysis of 118 structures at resolution of
at least 2.0 Angstroms and with the R-factor being no greater than
20%, over 90% of a good quality model would be expected in the
most favored regions (Procheck program). RMS deviations of
Table 3. Reporter metabolites around which most significant
gene expression changes occurred in response to FMP43
deletion in S. cerevisiae.
Metabolite
Number of
neighbors
P-
value
1,3-beta-D-Glucan 7 0,02
IMP 10 0,02
S-Adenosylmethioninamine 2 0,03
Mixt 2 0,03
L-Glutamate 5-semialdehyde 2 0,03
N-(L-Arginino)succinate 2 0,04
O-Phospho-4-hydroxy-L-threonine 2 0,04
3-Phosphoserine 2 0,04
Adenylylsulfate 3 0,04
Peptide 2 0,04
Orthophosphate 57 0,05
(R)-Pantoate 2 0,05
L-Citrulline 2 0,05
4-Phospho-L-aspartate 2 0,05
1-Phosphatidyl-1D-myo-inositol 3-phosphate 3 0,05
doi:10.1371/journal.pone.0013606.t003
Nutraceuticals & Yeast
PLoS ONE | www.plosone.org 9 October 2010 | Volume 5 | Issue 10 | e13606BRP44 Model 1 and its respective templates are shown in Table
S9. The overall statistics on structure quality as well as the overall
model quality (Z-score obtained from ProSA-web) are provided in
File S9.
Two potential protein-ligand binding sites from a total of 10
predicted sites (using Q-SiteFinder) were selected for molecular
docking studies. Predicted site-1 contained 13 amino acids
surrounding the cavity and had a site volume of 201 A ˚ 3. Predicted
site-2 contained 10 amino acids surrounding the cavity and had a
site volume of 115 A ˚ 3. Molecular docking was performed against
the BRP44 predicted binding site residues using FA as the ligand.
Analysis of best ligand pose energies indicated that predicted site-1
had higher affinity for FA. The molecular surface structure of
BRP44 with predicted binding site-1 is shown in Figure 4A along
with the Ramachandran plot obtained from Procheck (Figure 4B).
Protein-ligand binding site prediction and docking studies were
performed with AnFAEA (PDB Code: 1uwc). According to X-ray
crystallography data from Katherine et al. [47], FA interacts with
TYR80, LEU134, THR68 and SER133 in the binding site of
feruloyl esterase (AnFAEA) from Aspergillus niger. LEU199 and
ILE196 provide a hydrophobic environment in the binding
pocket. The molecular docking study reveals that FA indeed has
higher affinity for the binding site of BRP44 than the binding site
of AnFAEA. The comparison of docking energies and the binding
site residues are shown in File S9. According to X-ray
crystallography data from Prates et al. [48], FA interacts with
ASP980, TRP982, and ASN1023 in the binding site of feruloyl
esterase module of xylanase 10B from Clostridium thermocellum.
LEU958 provides a hydrophobic environment in the binding
pocket.
Protein-ligand binding site prediction and docking studies were
also performed with feruloyl esterase module of xylanase 10B
(PDB Code: 1gkl). The molecular docking results when using 1 gkl
and BRP44 reveal that in this case as well, FA has more affinity
towards the binding site of BRP44. The comparison of docking
energies and binding site residues are shown in Table S9.
The 3D structure of the FMP43 protein was determined and
after applying the same computational approach as above, we
observed that FA could bind in the two predicted sites of the
FMP43 protein, while the structure of the FMP43 protein shows
high similarity to 2BMX, a molecule of the Mycobacterium tuberculosis
defense system that has a key role during oxidative stress (Table
S9).
Discussion
A plethora of computational approaches can be used to
overcome the limitations of experimental techniques. Computa-
tional tools have become critical for the integration, representation
and visualization of heterogeneous genomics, proteomics and
biomedical data [49]. Experimental techniques, like yeast-two-
hybrid, have enabled to pair-wisely screen protein-protein
interactions [50]. Nevertheless, the study of protein complex data
involving more than two partners is relatively restricted due to the
limitations of the currently available high-throughput techniques.
Computational approaches complement experimental methods for
the detection of protein complexes using protein interaction data.
The study of protein interaction networks is important not only
from a theoretical point of view, but also has strong practical
applications towards the development of new drugs, which could
specifically interrupt or modulate protein interactions [51,52].
Yeast has several features making it an ideal model to study, not
only human disorders, but also the effect of nutraceuticals in the
prevention or progress of a disease [53,54]. Oxidative damage has
long been considered as a primary threat for neurons, both in
neurodegenerative disorders and aging. Free radicals, which
among others are produced during normal metabolism, can
trigger a series of events that disturb important aspects of the
normal cellular function, including enzymatic activity, protein
folding, transcription, ion channel activity, transporter function
and other processes. Such damage may contribute to a broad
range of diseases in the nervous system.
We presented a hypothesis-driven approach to elucidate the role
of a small model antioxidant molecule and understand how the
yeast cell tunes the flux of intermediates through metabolic routes
and restructures the cellular transcriptome and proteome in the
Figure 4. Homology modeling of the human brain protein BRP44 and ligand binding site prediction. (A) Molecular surface structure of
BRP44 showing predicted binding site-1 in cyan. (B) Ramachandran plot of BRP44 structure obtained from Procheck program. None of the amino acid
residues are in disallowed regions.
doi:10.1371/journal.pone.0013606.g004
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data obtained from our well-controlled yeast cultivations clearly
reflected the presence of an antioxidant compound 2demonstrat-
ing once again that the systematic use of this simple eukaryotic
organism can uncover important features of nutraceutical
compounds.
By using this external stimulus and network biology tools, we
identified a small, tightly connected sub-network reflecting the
biological signature of the yeast cell during stress, and we identified
the FMP43 protein 2which has not been previously functionally
characterized2 as an important player in the network architec-
ture. In silico analysis of FMP43 transcriptional regulation and
prediction of the post-translational modifications of the corre-
sponding protein revealed a putative new cell cycle regulatory
gene. This hypothesis was verified by the significant improvement
of the specific growth rate of the yeast cell after deletion of FMP43
and complements the recent finding about cell cycle delay
phenotypes observed by over-expression of FMP31 [43], a similar
protein with as well unknown function.
However, the linkage between antioxidant compounds and a
growth-controlling gene (FMP43) needs further investigation. The
ProtFun 2.2 server predicts FMP43 as a protein involved in
oxidative energy metabolism, possibly due to its role in the
metabolism of reactive oxygen species, which correlates well with
the high metabolic necessity when time between cell division cycles
is longer. This scenario could also explain the decrease in FMP43
expression levels upon addition of the antioxidant molecule and
the dual role of this protein in yeast.
Proteins can bind with many types of molecules using a wide
variety of binding sites. For example, binding sites used by natural
ligands or substrates, allosteric regulatory sites used by products or
reversible/irreversible inhibitors, and ‘special’ binding sites at
which an array of compounds 2such as drugs and antioxidants2
can bind [55]. Changes in the yeast phenotype stimulated by FA
may be due to the disruption of an existing protein interaction, by
changing the stability of the protein (or), by modulating the ability
of the protein to interact with other molecules, (or) by initiating a
series of signal transduction pathways upon binding to a particular
protein. Following the complexity of protein-ligand interactions
and fully characterizing by experimental means its effects on the
protein-protein interactions is challenging.
To extend our findings to human cells and identify proteins that
could serve as drug targets, we replaced the yeast FMP43 protein
with its human ortholog BRP44 in the genetic background of the
yeast strain Dfmp43. The conservation of the two proteins was
phenotypically evident, with BRP44 restoring the normal specific
growth rate of the wild type, which was significantly increased by
FMP43 deletion. PPIs have been proven crucial for all biological
processes. Hence, by performing PPI studies it is feasible to assign
functions to uncharacterized proteins and understand the
composition of protein complexes.
Taking into account the high potential of human PPIs for
understanding disease mechanisms and signaling cascades, we
investigated a representative part of the recently described human
interactome [56]. We identified three interaction partners for the
BRP44 protein, i.e. MAGED1, GABARAP and ACTC, all being
disease-associated proteins according to the OMIM morbidmap
(NCBI). Expression of members of several tumor-associated
antigen families, as for instance of the MAGE family, is restricted
to tumor cells and testes [57]. GABARAP is a GABA-A receptor-
associated protein. Type-A receptors for the neurotransmitter
GABA are ligand-gated chloride channels that mediate inhibitory
neurotransmission. GABARAP expression has been detected in all
tissues tested, namely heart, brain, placenta, lung, liver, skeletal
muscle, kidney and pancreas, suggesting potential involvement of
this protein in biological events other than interaction with GABA-
A receptors [58]. Morgensen et al. [59] stated that ACTC1 was the
first sarcomeric gene described to cause two different cardiomy-
opathies when being mutated, and hypothesized that ACTC1
mutations affecting sarcomere to the surrounding syncytium lead
to dilated cardiomyopathy. In addition, the Human Protein
Reference database indicates one more very interesting interaction
of BRP44 with the ribosomal P1 protein. In the recent study of
Martinez-Azorin et al. [60], the role of the ribosomal stalk P
proteins modulating ribosomal activity was investigated in human
cells using RNA interference. The loss of P1 protein produced a
decrease in the growth rate of the cells 2although the details of
this association are not yet understood2 which is in agreement
with the growth effects observed in our study when BRP44, an
interaction partner of P1 protein, was functionally expressed in
yeast cells.
Molecular docking methods have been used for decades to
determine the affinity of ligands/substrates towards the receptor/
protein/enzyme, and thus have acquired a great importance in
modern structure-based drug design [61–64]. A basic prerequisite
for docking studies is the 3D structure of the proteins under study.
Many proteins targeted for drug design do not have an
experimentally determined structure, which makes the scope of
docking studies limited. Homology modeling has been used to
generate structural models of proteins, which can still be used as
docking targets [65–67]. We predicted the 3D structure of the
yeast FMP43 protein, which is transcriptionally regulated after FA
addition. Homology modeling was also applied to predict the
structure of the human BRP44 protein, which restored the normal
phenotype in the FMP43 deletion yeast strain.
The second prerequisite for docking studies is to know the
location of the ligand’s binding site. The information related to
binding sites can be obtained experimentally through co-
crystallization of the protein-ligand complex. An alternative
approach is to identify structural or sequence similarity with a
known binding site, or use a computational tool to predict binding
sites on the protein of interest [68]. The binding sites in homology
models of the FMP43 and BRP44 proteins were computationally
predicted, and further docking studies were performed using FA as
the ligand. The results showed the affinity of FA towards both
proteins, which is in line with our phenotypic experimental
observations.
Comparing the protein-protein and protein-ligand interactions
of simple cellular systems, for instance the yeast with the human
system, promises much for the future 2even though it limits the
resolution of the results. The platform presented here strongly
suggested anti-oxidant therapeutic targets 2as demonstrated
through identification and characterization of yeast and human
orthrolog protein-protein interaction networks2 but requires
further in vivo validation. Similar to pharmacological therapeutic
discovery, nutraceutical target identification and screening 2while
often limiting and resource-intensive2 may be enhanced through
the approach of yeast physiological and network biology analysis
demonstrated here.
Supporting Information
Table S1 Contains two Tables, in the first one there is a detailed
description for the calculation of the Degree of Reduction (DOR)
per C-mole of the metabolites identified during S. cerevisiae
cultivations. The second Table contains the comparison of the
intracellular and extracellular metabolite levels identified in S.
cerevisiae cultivations in the presence and absence of ferulic acid
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(-O2). The values represent ratios while the last column indicates
the DOR of each metabolite.
Found at: doi:10.1371/journal.pone.0013606.s001 (0.16 MB
PDF)
Table S2 Summary of the significant effects of FA on gene
expression levels of S. cerevisiae. The list provided here specifies
the FA-specific genes and contains genes with significant
differential regulation when comparing the S. cerevisiae growth
in the presence and absence of FA under aerobic and anaerobic
conditions.
Found at: doi:10.1371/journal.pone.0013606.s002 (0.12 MB
PDF)
Table S3 Special protein-protein interaction considerations
taken during the construction of the FA-specific primary network.
Found at: doi:10.1371/journal.pone.0013606.s003 (0.05 MB
PDF)
Table S4 Statistically significant protein complexes of the
primary FA-specific network predicted by the MCODE clustering
algorithm.
Found at: doi:10.1371/journal.pone.0013606.s004 (0.18 MB
PDF)
Table S5 Sub-cellular localization (Cerebral) and functional
enrichment (BiNGO) analyses of the ACTMOD network.
Found at: doi:10.1371/journal.pone.0013606.s005 (0.52 MB
PDF)
Table S6 List of proteins participating in the FMP43 complex
and their human orthology.
Found at: doi:10.1371/journal.pone.0013606.s006 (0.07 MB
PDF)
Table S7 Functional and structural characterization of the
FMP43 protein using diverse bioinformatics tools and prediction
servers (ProtFun, TMHMM, NetNES, SignalP, TargetP, NetPho-
sYeast, NetAcet and YinOYang servers).
Found at: doi:10.1371/journal.pone.0013606.s007 (0.03 MB
PDF)
Table S8 The gene deletion and over-expression strategies
followed for the construction of the relevant yeast strains used in
the present study, namely CEN.PK 113-5D/I ˆ¿fmp43 and
CEN.PK 113-5D/I ˆ¿fmp43-pRS426-BRP44.
Found at: doi:10.1371/journal.pone.0013606.s008 (0.61 MB
PDF)
Table S9 Detailed file with the homology modelling, structure
validation, protein-ligand binding site prediction and molecular
docking studies of the BRP44 and FMP43 proteins.
Found at: doi:10.1371/journal.pone.0013606.s009 (0.56 MB
PDF)
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